Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Wednesday, March 18, 2015 9:31:59 AM
It diluted the stock unwisely last year, it should have diluted it to raise money when price was high and not for excessive compensation.
Yeah, it gives us some tax assets....but they are not worth much when we are so far from profitability.
Biozone assets need to be sold at any price as soon as possible....it's fine having a warehouse in California, and perhaps even a research lab but such a small manufacturing facility that uses most of it's runtime on producing shampoos etc, is just a waste of time. The cost of supervising such a small facility so far away from the headquarters doesn't make any sense.
Sell the company to some investors in the local area...they are the ones that can use that...not Musclepharm.
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM